// App-Quantinova.ai

1199 : A network biology screen reveals ligand-receptor pathway connections and resistance mechanisms to RTK-directed therapies in cancer cells

Researchers

Presenter

  • Kristina Masson

Principal Investigators

  • Andreas Raue

  • Gavin MacBeath

Medical Centers

  • Merrimack Pharmaceuticals, Cambridge, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Epithelial Cell Adhesion Molecule

Drug/Treatment

  • Seribantumab

  • MM131

  • MM141

  • MM151

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved